Intravenous immunoglobulin therapy for hyperbilirubinemia caused by Rhesus hemolytic disease.
Merchant
R H
RH
Department of Pediatrics, B. Nanavati Hospital, Bombay.
Pradeep
S
S
D001663:Bilirubin / Q000097:blood; D004899:Erythroblastosis, Fetal / Q000097:blood / Q000150:complications*; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D006932:Hyperbilirubinemia / Q000097:blood / Q000209:etiology* / Q000628:therapy*; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007231:Infant, Newborn; D007236:Infant, Small for Gestational Age; D008297:Male; D012204:Rh-Hr Blood-Group System
D006454:Hemoglobins; D016756:Immunoglobulins, Intravenous; D012204:Rh-Hr Blood-Group System; D001663:Bilirubin